This trial is expected to be the first of two pivotal Phase III trials required to support filing for regulatory approval for GAMMAGARD LIQUID as a potential treatment for Alzheimer's disease.
</str...
-
Untitled Comment
Sue
Monday, September 22, 2008 at 08:46 PM























Thanks so much Bob. This is great information for our members. Sounds like a serious research project. It can only be a good thing that scientists are moving forward in trying everything possible to find a cure.
All the best, sue
For more information , check out the national organizations that support Alzheimer's Disease.
reply